The discovery and development of biologics is complex, time-consuming and expensive because they’re derived from living organisms. A new drug discovery company based in Madison, Wis. called Invenra Inc. says it has a platform that could overcome some of the barriers that limit the discovery of new biologic drugs in areas like cancer, Alzheimer’s disease and diabetes. The company disclosed in a securities filing that it has raised $3 million. Read the full MedCity News story here.
;
#Milwaukee-area firms named finalists for the 2024 #Wisconsin #Innovation Awards. via @mkebizjournal @wiscia
Milwaukee-area firms named finalists for 2024 Wisconsin Innovation Awards
Four Milwaukee-area firms have been named finalists in the 2024 Wisconsin Innovation Awards, honoring the state's most...
loom.ly
Calendar 2023 was #Wisconsin’s third highest year for early stage investment dollars at $490 million. https://loom.ly/u9LHK1o #venturecapital #startup
Investors say last year’s lower VC total was no surprise, follows national trend. https://loom.ly/mWu59w4 via @wisbusiness #venturecapital #Wisconsin
.@exactsciences awards grants to 28 organizations focused on increasing colorectal #cancer screening. #prevention #health
Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer Screening
Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded a total of $1.5 million to 28 organizatio
loom.ly
.@uwhealth East Madison Hospital achieves an important #stroke certification. https://loom.ly/o4KQQKA via @wisbusiness #Wisconsin #healthcare
Check out the finalists for the #Wisconsin #Innovation Awards. https://loom.ly/kTF4aZs via @wisbusiness @wiscia #startup